Mylan (United States)

Mylan (United States)

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Mylan (United States), United States, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

55%


Total
Publications

4.1K


Total Open
Publications

2.2K


Total
Citations

156K


Open Access
Percentage

55%


Total
Publications

4.1K


Total Open
Publications

2.2K


Total
Citations

156K

Wikipedia

Website

download

Breakdown

16% 26% 12% 46%

Publisher Open

16%

Both

26%

Other Platform Open

12%

Closed

46%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200220240260280300Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

37%OA Journal

OA Journal 37%

641

Hybrid 26%

438

No Guarantees 37%

624

Other Platform Open

Institution 79%

1.2K

Domain 31%

496

Other Internet 13%

203

Preprint 5%

76

Public 3%

44

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
497
University of Milan
Institution
424
doaj.org OAI-PMH Repository
Institution
268
University of Castilla-La Mancha
Institution
161
DOI
Other Internet
133
Unknown Repository
Other Internet
100
Istituto Nazionale di Fisica Nucleare, Sezione di Catania
Institution
100
University of Milano-Bicocca
Institution
98
Office of Scientific and Technical Information
Institution
50
University of Modena and Reggio Emilia
Institution
44
1 / 20

Data updated 12 August 2026

Share

Share

Share